Research Goals

Our research goals include:

1. Characterizing the role of toll like receptors in lung ischemia reperfusion injury

2. Developing novel therapeutic approaches for prevention of lung ischemia reperfusion injury

3. Identifying the regulatory pathways that drive ischemic tolerance.

Funding

Currently our research is made possible by these organizations:

• Bayer Institute for Health Care Communication

• International Society for Heart and Lung Transplantation XVIVO Perfusion, Inc.

• National Heart, Lung, and Blood Institute

• National Institutes of Health

• Roche Laboratories, Inc.

• US Department of Veterans Affairs

• Thoracic Surgery Foundation for Research and Education

• Western Thoracic Surgical Association